TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Cap table
Cap table
Built by 6ix from TransCode Therapeutics, Inc.’s releases · as of Nov 12, 2026
- Common shares
- 17,303,883
- Fully diluted
- 17,303,883
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 17,303,883 | Nov 12, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · US$0.86 · expire about Mar 2030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 12, 2026 | 17,303,883 |